Guiyu Wang

Guiyu Wang


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2023 in Oncology Letters
Verified
Journal Article
Open access
PDF file
CWChunlin Wang
Chunlin Wang
HZHao Zhang
Hao Zhang
YLYunxiao Liu
Yunxiao Liu
YWYuliuming Wang
Yuliuming Wang
HHHanqing Hu
Hanqing Hu
GWGuiyu Wang
Guiyu Wang
Colorectal cancer (CRC) is a malignant tumor and a major cause of morbidity and mortality globally. The classic Tumor‑Node‑Metastasis staging system, which currently underlies the diagnosis and treatment of CRC, is primarily a ‘one drug fits all’ model for patients exhibiting the same pathological features. However, a high degree of variability has been established in the long‑term survival outcomes of patients with CRC with similar pathological types and stages, which can be partially attributed to tumor‑specific molecular biology to some extent. Molecular classification of CRC can further assist with understanding the biological behavior of tumor genesis, development and prognosis, and assist clinicians in improving or customizing the treatment strategy of CRC. In the present study, clinical studies carried out to date are reviewed, and their clinical value is discussed. A multilevel overview of the major molecular types of CRC is provided, in the hope that investigators are encouraged to combine multiple omics studies for interrogating cancer.

16 April 2025 in BMC Surgery
Verified
Journal Article
Open access
PDF file
CWChunlin Wang
Chunlin Wang
YWYuliuming Wang
Yuliuming Wang
HZHao Zhang
Hao Zhang
YLYunxiao Liu
Yunxiao Liu
XZXin Zhang
Xin Zhang
GWGuiyu Wang
Guiyu Wang
The KangDuo Surgical Robot-01 (KD-SR-01) system is a recently introduced robot-assisted endoscopic surgical device originally designed in China. The purpose of this prospective cohort study was to ascertain whether the KD-SR-01 system was substantially equivalent to a comparable robotic device in terms of safety, efficacy and treatment costs during colorectal cancer resection, and evaluate the learning curve of KangDuo robotic surgery. From October 2022 to May 2023, 50 patients (aged 18–80 years) with colorectal cancer were enrolled and randomly assigned to either the KangDuo group (KD-SR group; 26 patients) or the Da Vinci group (DV group; 24 patients). The primary endpoints were surgical success and conversion rates. In addition, cumulative summation (CUSUM) was used to plot the learning curve of KangDuo robot-assisted colorectal surgery and identify turning point (TP) case. The two cohorts both successfully completed the procedure without any conversion to open or laparoscopic surgery. Time to first flatus and incidence of perioperative adverse events were equivalent between the KD-SR and DV groups. Additionally, no disparities were observed in pathological outcomes. Duration of operation and console time of the KD-SR group were significantly longer than those of the DV group. However, DV group had higher total hospitalization costs. With CUSUM analysis, TP for docking time, console time and duration of operation of KD-SR group were seen at the 11th case. Considering the complexity of the procedure, KangDuo robot-assisted colorectal cancer surgery is safe and reproducible for the surgical management of colorectal cancer. In addition, 11 procedures seem to be the number required to reach the learning curve plateau in terms of operative time by the experienced surgeon. The study was registered at www.chictr.org.cn (Registration number: ChiCTR2200063172, Data of Registration: 2022-09-01).

12 January 2026 in International Journal of Surgery
Verified
Journal Article
Open access
CWChunlin Wang
Chunlin Wang
YWYuliuming Wang
Yuliuming Wang
HZHao Zhang
Hao Zhang
YLYunxiao Liu
Yunxiao Liu
HJHao Jiang
Hao Jiang
GWGuiyu Wang
Guiyu Wang
Purpose: Although robotic surgery has advanced minimally invasive techniques, its ergonomic limitations pose significant musculoskeletal risks to surgeons. This study evaluated whether the Kangduo SR-01 (KD) open console system mitigates intraoperative ergonomic strain while preserving technical performance during robotic colorectal resection. Methods: This study utilized data from a multicenter randomized controlled non-inferiority trial comparing the efficacy and safety of KD versus Da Vinci (DV) robotic systems in assisting colorectal cancer resection. The assessment framework included ergonomic strain (Borg CR-10 Scale), team coordination (Oxford NOTECHS II), and blinded video-based technical performance analysis [Objective Structured Assessment of Technical Skills (OSATS)]. Results: A total of 100 patients were included in the modified intention-to-treat analysis: 50 in the KD group and 50 in the DV group. Body mass index (BMI) and resection types were comparable between groups. Postural demands were significantly higher for neck and back during DV procedures. Discomfort increased significantly more over time (up to 3 h) in the DV group for both neck [MD (95% c.i.) −0.889 (−1.077, −0.701), P < 0.001] and back [MD (95% c.i.) −0.606 (−0.847, −0.364), P < 0.001]. Notably, both systems achieved equivalent technical proficiency (OSATS total: 29.0 vs. 29.0, P = 0.259) and team coordination (NOTECHS II: 74.0 vs. 73.0, P = 0.120) with comparable short-term outcomes. Conclusions: The Kangduo SR-01 open console system significantly alleviated musculoskeletal strain, particularly in the neck and back, during robotic colorectal surgery while maintaining equivalent technical performance. These findings position open console platforms as a viable solution to ergonomic challenges in robotic surgery without compromising team dynamics or procedural efficiency.

13 June 2025 in Journal of Visualized Experiments
Verified
Journal Article
Closed access
PDF file
CWChunlin Wang
Chunlin Wang
YWYuliuming Wang
Yuliuming Wang
YLYunxiao Liu
Yunxiao Liu
HZHao Zhang
Hao Zhang
XZXin Zhang
Xin Zhang
GWGuiyu Wang
Guiyu Wang
Robot-assisted natural orifice specimen extraction surgery (NOSES) for sigmoid colon cancer represents an innovative, minimally invasive surgical technique that integrates the benefits of minimally invasive surgery with natural orifice specimen extraction. In this study, a 67-year-old male patient diagnosed with sigmoid colon cancer underwent Kangduo surgical robot-assisted NOSES, with a total operative time of 290 min and an estimated intraoperative blood loss of 50 mL. The procedure involved robotic-assisted radical resection of the sigmoid colon, regional lymphadenectomy, and specimen extraction through a natural orifice. Postoperative histopathological analysis confirmed the absence of residual malignancy in the resected sigmoid colon, while 12 pericolic lymph nodes exhibited reactive hyperplasia. Both the proximal and distal surgical margins were negative for malignancy. The patient had an uneventful recovery and was discharged on postoperative day 7. The precision and flexibility of the robotic system facilitated NOSES by minimizing abdominal wall trauma, reducing postoperative complications, and shortening recovery time. This finding indicates that robot-assisted NOSES is a safe and feasible approach for the surgical treatment of sigmoid colon cancer, though further clinical experience and long-term follow-up are required to comprehensively assess its efficacy.

13 June 2025
Verified
Dataset
Closed access
PDF file
CWChunlin Wang
Chunlin Wang
YWYuliuming Wang
Yuliuming Wang
YLYunxiao Liu
Yunxiao Liu
HZHao Zhang
Hao Zhang
XZXin Zhang
Xin Zhang
GWGuiyu Wang
Guiyu Wang
Robot-assisted natural orifice specimen extraction surgery (NOSES) for sigmoid colon cancer represents an innovative, minimally invasive surgical technique that integrates the benefits of minimally invasive surgery with natural orifice specimen extraction. In this study, a 67-year-old male patient diagnosed with sigmoid colon cancer underwent Kangduo surgical robot-assisted NOSES, with a total operative time of 290 min and an estimated intraoperative blood loss of 50 mL. The procedure involved robotic-assisted radical resection of the sigmoid colon, regional lymphadenectomy, and specimen extraction through a natural orifice. Postoperative histopathological analysis confirmed the absence of residual malignancy in the resected sigmoid colon, while 12 pericolic lymph nodes exhibited reactive hyperplasia. Both the proximal and distal surgical margins were negative for malignancy. The patient had an uneventful recovery and was discharged on postoperative day 7. The precision and flexibility of the robotic system facilitated NOSES by minimizing abdominal wall trauma, reducing postoperative complications, and shortening recovery time. This finding indicates that robot-assisted NOSES is a safe and feasible approach for the surgical treatment of sigmoid colon cancer, though further clinical experience and long-term follow-up are required to comprehensively assess its efficacy.

3 November 2026 in Discover Oncology
Verified
Journal Article
Open access
PDF file
NZNana Zhang
Nana Zhang
LCLingling Cai
Lingling Cai
XGXinling Guo
Xinling Guo
GWGuiyu Wang
Guiyu Wang
BSBin Shen
Bin Shen
Background This study employed systematic bioinformatics analyses and three machine learning-based feature selection frameworks to explore candidate key genes underlying diabetes-associated breast cancer (BC). Methods Gene expression profiles of breast cancer were retrieved from The Cancer Genome Atlas (TCGA) database, and diabetes-related expression data were obtained from the Gene Expression Omnibus (GEO) dataset GSE95849. Shared differentially expressed genes (DEGs) were screened using the limma package in R software. Biological functions and signaling pathways of these DEGs were annotated via Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses using the clusterProfiler package. Three machine learning-based feature selection approaches—LASSO regression, support vector machine recursive feature elimination (SVM-RFE), and random forest coupled with Boruta feature selection—were used to identify hub genes associated with diabetes-related breast cancer. The prognostic value of candidate genes was validated in both TCGA-BC and METABRIC-BC cohorts, and protein expression levels were further verified by immunohistochemistry in clinical breast cancer tissues. Results A total of 96 overlapping DEGs with fully concordant direction of regulation (69 upregulated and 27 downregulated) were identified for in-depth analyses. Nine hub genes linked to diabetes-associated breast cancer were screened out, including ATP1A2, DNAJC1, DPT, EFNB3, EGFLAM, RAB31, TPPP, VCAN, and ZNF467. Among them, DNAJC1, RAB31, VCAN, and ZNF467 were upregulated, whereas ATP1A2, DPT, EFNB3, EGFLAM, and TPPP were downregulated. Functional enrichment analysis indicated that cell division, endocrine resistance, and the cAMP signaling pathway were critically implicated in diabetes-associated breast cancer. Survival analysis in the TCGA-BC cohort revealed that high expression of ATP1A2, EFNB3, RAB31, and TPPP was significantly correlated with favorable overall survival. Similarly, in the METABRIC-BC cohort, elevated expression of ATP1A2, DPT, EFNB3, RAB31, VCAN, and ZNF467 predicted better overall survival. ATP1A2 and RAB31 were identified as the candidate core genes for further investigation. In clinical diabetes-associated breast cancer tissues, ATP1A2 was notably downregulated while RAB31 was upregulated, suggesting their potential roles in the progression of diabetes-related breast cancer. Conclusions Our findings indicate that ATP1A2 and RAB31 may serve as candidate key genes in diabetes-associated breast cancer, which offers useful clues for future mechanistic research and the development of targeted therapeutic strategies for this specific subtype of breast cancer.